JP2025506844A5 - - Google Patents

Info

Publication number
JP2025506844A5
JP2025506844A5 JP2024550618A JP2024550618A JP2025506844A5 JP 2025506844 A5 JP2025506844 A5 JP 2025506844A5 JP 2024550618 A JP2024550618 A JP 2024550618A JP 2024550618 A JP2024550618 A JP 2024550618A JP 2025506844 A5 JP2025506844 A5 JP 2025506844A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
compound
formula
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024550618A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506844A (ja
Filing date
Publication date
Priority claimed from NL2031091A external-priority patent/NL2031091B1/en
Application filed filed Critical
Publication of JP2025506844A publication Critical patent/JP2025506844A/ja
Publication of JP2025506844A5 publication Critical patent/JP2025506844A5/ja
Pending legal-status Critical Current

Links

JP2024550618A 2022-02-28 2023-02-28 加齢及び加齢関連障害の治療又は予防のためのクロマノール化合物 Pending JP2025506844A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2031091 2022-02-28
NL2031091A NL2031091B1 (en) 2022-02-28 2022-02-28 Chromanol compounds for treatment or prophylaxis of ageing and ageing-associated disorders
PCT/NL2023/050095 WO2023163596A1 (en) 2022-02-28 2023-02-28 Chromanol compounds for treatment or prophylaxis of ageing-associated disorders

Publications (2)

Publication Number Publication Date
JP2025506844A JP2025506844A (ja) 2025-03-13
JP2025506844A5 true JP2025506844A5 (https=) 2026-03-02

Family

ID=83271289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024550618A Pending JP2025506844A (ja) 2022-02-28 2023-02-28 加齢及び加齢関連障害の治療又は予防のためのクロマノール化合物

Country Status (10)

Country Link
US (1) US20250177384A1 (https=)
EP (1) EP4486317A1 (https=)
JP (1) JP2025506844A (https=)
CN (1) CN118742301A (https=)
AU (1) AU2023225518A1 (https=)
CA (1) CA3252944A1 (https=)
CL (1) CL2024002555A1 (https=)
NL (1) NL2031091B1 (https=)
WO (1) WO2023163596A1 (https=)
ZA (1) ZA202406418B (https=)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006105806A1 (en) 2005-04-07 2006-10-12 Miso Sabovic Delaying the ageing process and disorders caused by ageing
EP2680838A1 (en) 2011-02-28 2014-01-08 Farmicom Pharmaceutical Company D.O.O. TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
KR102137450B1 (ko) 2012-07-12 2020-07-27 콘드리온 아이피 비.브이. 미토콘드리아 질환을 치료하기 위한 크로마닐 유도체
NL2010010C2 (en) 2012-12-19 2014-06-23 Sulfateq B V Compounds for protection of cells.
WO2015148522A1 (en) 2014-03-24 2015-10-01 Seals Douglas R Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotide
NL2013012B1 (en) * 2014-06-17 2016-07-05 Sulfateq Bv Compounds for the treatment of chronic obstructive airway diseases.
US10815211B2 (en) 2015-10-08 2020-10-27 Khondrion Ip B.V. Compounds for treating mitochondrial disease
ES2959243T3 (es) * 2017-04-05 2024-02-22 Khondrion Ip B V Nuevo tratamiento de enfermedades mitocondriales
EP3672593B1 (en) * 2017-08-25 2024-12-18 Sulfateq B.V. Medicaments for the treatment of vasoconstriction related diseases or disorders
WO2019038360A1 (en) * 2017-08-25 2019-02-28 Sulfateq B.V. 6-CHROMANOL DERIVATIVES FOR USE AS A MEDICINAL PRODUCT
NL2024431B1 (en) * 2019-12-11 2021-09-07 Sulfateq Bv Compounds for treatment of alzheimer’s disease
NL2026511B1 (en) * 2020-09-21 2022-05-24 Sulfateq Bv Compounds for treatment of heart failure

Similar Documents

Publication Publication Date Title
JP2020125355A (ja) 併用療法
JP2007302690A5 (https=)
RU2006137706A (ru) 9-замещенное производное 8-оксоаденина
JP7083005B2 (ja) 眼科用組成物
KR970701698A (ko) 프로스타글란딘 i₂작용물질로서의 나프탈렌 유도체(naphthalene derivatives as prostaglandin i₂agonists)
JPH08510479A (ja) 眼の炎症障害を処置するための3‐ベンゾイルフェニル酢酸誘導体を含む局所的に投与可能な組成物
JP2004533450A5 (https=)
EP0179808B1 (en) Pharmaceutical composition suitable for treatment or prophylaxis of cardiac disorders
AR065297A1 (es) Formulaciones biodisponibles de compuestos heterociclicos
EP0499544B1 (fr) Utilisation de dérivés de tétrahydrothiénopyridine comme inhibiteurs de l'angiogénèse
JP2025506844A5 (https=)
JP2023529612A5 (https=)
EP0194906B1 (fr) Esters hérérocycliques dissymétriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procédé de préparation et utilisation en thérapeutique
KR880001593A (ko) 4-(아로일아미노)피페리딘부탄아미드 유도체
AU618279B2 (en) Anxiolytically active piperazine derivatives
ATE289583T1 (de) Stereoisomere von propyl-isopropylacetamid, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen
JPS61180785A (ja) 新規な治療用組成物
SE9900190D0 (sv) New compounds
RU2008101776A (ru) Соединения для ингибирования обратного захвата 5-гидрокситриптамина и норэпинефрина или для лечения депрессивных состояний, способы их получения и применения
NL2031091B1 (en) Chromanol compounds for treatment or prophylaxis of ageing and ageing-associated disorders
JP2022524152A5 (https=)
RU2223947C2 (ru) ПРОИЗВОДНОЕ ФЕНИЛОВОГО ЭФИРА α-АМИНОКИСЛОТЫ
RU2005137701A (ru) Применение производных феноксиуксусной кислоты для лечения гиперактивности мочевого пузыря
RU2001104896A (ru) Производные фенилового эфира альфа-аминокислоты
RU2374235C2 (ru) Производные хиназолинона и их применение в качестве агонистов каннабиноидного (св) рецептора